IP Library Granted Patent US 11,377,496
Granted Patent B2
US 11,377,496 · App. 16/420,062 · Granted Jul 5, 2022

Targeting agent antibody conjugates and uses thereof

Inventors: Chanhyuk Kim (Daejeon, KR); Jun Y. Axup (San Diego, CA); Hwayoung Yun (Daejeon, KR); Peter G. Schultz (La Jolla, CA); Jennifer Ma (La Jolla, CA); Jiayin Shen (San Diego, CA); Pengyu Yang (San Diego, CA)
Assignee: THE SCRIPPS RESEARCH INSTITUTE
C07K16/2809A61K39/3955A61K39/39558A61K47/542C07C275/16C07C275/24C07D249/04C07K16/2803C07K16/2806C07K16/2851C07K16/2863C07K16/2887C07K16/2896C07K16/3069C07K16/32C07K16/468A61K2039/505C07K2317/31C07K2317/33C07K2317/35C07K2317/52C07K2317/55C07K2317/56C07K2317/73C07K2317/92C07K2317/94Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,377,496
App. No.
16/420,062
Granted
Jul 5, 2022
Kind
B2
Abstract

Methods, compositions and uses are provided for bispecific antibodies comprising one or more unnatural amino acids. The bispecific antibodies may bind to two or more different receptors, co-receptors, antigens, or cell markers on one or more cells. The bispecific antibodies may be used to treat a disease or condition (e.g., cancer, autoimmune disease, pathogenic infection, inflammatory disease). The bispecific antibodies may be used to modulate (e.g., stimulate or suppress) an immune response.

Claims (2)

1. A compound comprising:

or a stereoisomer thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2020
From: KIM, CHANHYUK; AXUP, JUN Y.; YUN, HWAYOUNG; SCHULTZ, PETER G.; MA, JENNIFER; SHEN, JIAYIN; YANG, PENGYU
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 053298/0366 →
Continuity (4)
Division 14774647
Provisional Application 61783426 · Mar 14, 2013
Provisional Application 61839330 · Jun 25, 2013
Related Publication 20190315863A1 · Oct 17, 2019